Indomethacin Export Market Intelligence: India's 139 Suppliers Shipping to 70 Countries — TransData Nexus 2026

Q: Who are the top indomethacin exporters from India?

The top indomethacin exporters from India are: 1. HETERO LABS LIMITED — $3.9M (41.6% market share); 2. GLENMARK PHARMACEUTICALS LIMITED — $1.6M (16.8% market share); 3. ZYDUS LIFESCIENCES LIMITED — $657.5K (7.0% market share); 4. GLENMARK PHARMACEUTICALS LTD — $618.0K (6.6% market share); 5. LEBEN LABORATORIES PRIVATE LIMITED — $419.7K (4.5% market share). Together they account for 76.5% of India's total indomethacin export value.

Q: What is the total export value of indomethacin from India?

The total export value of indomethacin from India is $9.4M USD, recorded across 1,248 shipment transactions from 139 active exporters to 70 destination countries. The average shipment value is $7.5K.

Q: Which countries import indomethacin from India?

India exports indomethacin to 70 countries worldwide. The top importing countries are: UNITED STATES (68.0% share, $6.4M), CANADA (4.3% share, $405.8K), UGANDA (3.3% share, $305.3K), CHILE (2.9% share, $268.6K), TAJIKISTAN (2.4% share, $226.3K). These five markets account for 80.9% of total export value.

Q: What is the HS code for indomethacin exports from India?

The primary HS code for indomethacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of indomethacin exports from India?

The average unit price for indomethacin exports from India is $3.86 USD per unit, with prices ranging from $0.00 to $61.92 depending on formulation, packaging, and order volume. The total market is valued at $9.4M across 1,248 shipments.

Q: Which ports handle indomethacin exports from India?

The primary ports for indomethacin exports from India are DELHI AIR CARGO ACC (INDEL4) (13.9% of shipments), SAHAR AIR (13.1% of shipments), SAHAR AIR CARGO ACC (INBOM4) (12.6% of shipments), DELHI AIR (9.1% of shipments), NHAVA SHEVA SEA (INNSA1) (7.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of indomethacin?

India is one of the world's leading exporters of indomethacin due to its large base of 139 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports indomethacin to 70 countries, demonstrating 36% global market coverage.

Q: What certifications do Indian indomethacin exporters need?

Indian indomethacin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import indomethacin from India?

There are 242 registered buyers importing indomethacin from India, spread across 70 countries. The repeat buyer rate is 51.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top indomethacin supplier from India?

HETERO LABS LIMITED is the leading indomethacin exporter from India with a market share of 41.6% and total export value of $3.9M across 144 shipments. The top 5 suppliers together control 76.5% of total export value.

Suresh Sormare

Indomethacin

India Pharmaceutical Trade Intelligence

$9.4M139 Suppliers70 CountriesHS 30049099

ExportsIndia → UNITED STATES68.0%India → CANADA4.3%

ImportsUNITED STATES → India$205.8K CANADA → India$68.6K

#1 Supplier: HETERO LABS #1 Buyer: GLENMARK PHARMACEUTICALS

Indomethacin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Indomethacin to the World

Between 2022 and 2026, India exported $9.4M worth of indomethacin across 1,248 verified shipments to 70 countries — covering 36% of world markets in the Analgesics & Antipyretics segment. The largest destination is UNITED STATES (68.0%). HETERO LABS LIMITED leads with a 41.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Indomethacin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Indomethacin export data snapshot — $9.4M · 139 exporters · 70 countriesTransData Nexus · Indian Customs Data

Top Indomethacin Exporters from India

139 active exporters · Ranked by export value

View all 139 →

Top Indomethacin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	HETERO LABS LIMITED	$3.9M	144	3	41.6%
2	GLENMARK PHARMACEUTICALS LIMITED

Top Countries Importing Indomethacin from India

70 destination markets · Ranked by import value

All 70 countries →

Top Countries Importing Indomethacin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$6.4M	68.0%
2	CANADA	$405.8K	4.3%
3	UGANDA	$305.3K	3.3%
4	CHILE	$268.6K	2.9%
5	TAJIKISTAN	$226.3K	2.4%
6	KENYA	$212.5K	2.3%
7	ETHIOPIA	$169.0K	1.8%
8	COSTA RICA	$132.8K	1.4%
9	SOMALIA	$119.1K	1.3%
10	MAURITIUS	$117.3K	1.3%

UNITED STATES is India's largest indomethacin export destination, absorbing 68.0% of total exports worth $6.4M. The top 5 importing countries — UNITED STATES, CANADA, UGANDA, CHILE, TAJIKISTAN — together account for 80.9% of India's total indomethacin export value. The remaining 65 destination countries collectively receive the other 19.1%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Indomethacin to India?

6 origin countries · Total import value: $275.5K

India imports indomethacin from 6 countries with a combined import value of $275.5K. The largest supplier is UNITED STATES ($205.8K, 29 shipments), followed by CANADA and GUYANA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Indomethacin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$205.8K	29	74.7%
2	CANADA	$68.6K	10	24.9%
3	GUYANA	$633	1	0.2%
4	UNITED KINGDOM	$208	2	0.1%
5	SOUTH AFRICA	$99	4	0.0%
6	TAIWAN	$87	2	0.0%

UNITED STATES is the largest supplier of indomethacin to India, accounting for 74.7% of total import value. The top 5 origin countries — UNITED STATES, CANADA, GUYANA, UNITED KINGDOM, SOUTH AFRICA — together supply 100.0% of India's indomethacin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Indomethacin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), has been approved in the United States through multiple Abbreviated New Drug Applications (ANDAs). According to the FDA's Orange Book, numerous generic versions of indomethacin are available, indicating a well-established market presence. The most recent ANDA approval for indomethacin was granted in March 2025, reflecting ongoing interest and competition in the generic NSAID market.

The United States is the primary destination for indomethacin exports from India, accounting for 68.0% of the total export value. This significant market share underscores the importance of compliance with FDA regulations for Indian exporters. To date, there have been no import alerts issued by the FDA specifically for indomethacin, suggesting that Indian manufacturers have maintained compliance with U.S. regulatory standards. The regulatory pathway for indomethacin involves the submission of an ANDA, demonstrating bioequivalence to the reference listed drug, and adherence to current Good Manufacturing Practices (cGMP) as mandated by the FDA.

2EU & UK Regulatory Framework

In the European Union, indomethacin is subject to marketing authorization by the European Medicines Agency (EMA). The EMA requires comprehensive data on quality, safety, and efficacy for approval. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval process. Both agencies mandate compliance with EU Good Manufacturing Practice (GMP) guidelines to ensure product quality and patient safety.

3WHO Essential Medicines & Global Standards

Indomethacin is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025. This inclusion highlights its recognized importance in treating priority health conditions globally. The drug is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality specifications across different regions.

4India Regulatory Classification

In India, indomethacin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for indomethacin, allowing market-driven pricing. For export purposes, Indian manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national export regulations.

5Patent & Exclusivity Status

The primary patents for indomethacin have expired, leading to a competitive generic market. This expiration has facilitated the entry of multiple generic manufacturers, contributing to the drug's widespread availability and affordability.

6Recent Industry Developments

In June 2025, the NPPA announced a revision of the ceiling prices for several essential medicines; however, indomethacin was not included in this list, allowing its pricing to remain market-driven.

In August 2025, the EMA issued updated guidelines on the manufacturing of NSAIDs, emphasizing stricter controls on impurities. Indian exporters targeting the EU market must ensure compliance with these enhanced standards to maintain market access.

In October 2025, the WHO released the 24th edition of the Model List of Essential Medicines, reaffirming indomethacin's status as an essential medicine. This inclusion underscores its continued relevance in global healthcare.

In December 2025, the FDA updated its guidance on bioequivalence studies for generic NSAIDs, including indomethacin. Manufacturers are advised to align their study designs with these new recommendations to facilitate ANDA approvals.

In February 2026, the CDSCO implemented a new online portal for the submission of export NOCs, streamlining the process for Indian pharmaceutical companies exporting drugs like indomethacin.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Indomethacin

Retail & reference prices across 9 markets vs. India FOB export price of $3.86/unit

Global Price Benchmark for Indomethacin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.15–$0.30	USD	According to a US national survey, the average pharmacy acquisition cost for Indomethacin 25 mg capsules ranges from $0.15 to $0.30 per unit.
United Kingdom	$0.92	GBP	The NHS Drug Tariff lists Indomethacin 50 mg capsules at £0.71 per unit.
Germany	$0.88	EUR	The German Federal Joint Committee (G-BA) sets the reference price for Indomethacin 50 mg capsules at €0.80 per unit.
Australia	$0.75

Supply Chain Risk Assessment — Indomethacin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where approximately 41% of KSMs used in U.S.-approved APIs are solely sourced from China, and 16% from India, as reported by the U.S. Pharmacopeia in October 2025.

Recent disruptions have highlighted the vulnerabilities in this supply chain. In February 2025, the FDA issued warning letters to API manufacturers in China and India for significant deviations from current Good Manufacturing Practices (cGMP), underscoring ongoing quality concerns. Such regulatory actions can lead to production halts, affecting the availability of essential drugs like Indomethacin.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters account for 76.5% of Indomethacin exports, with HETERO LABS LIMITED alone contributing 41.6%. This high supplier concentration poses a significant risk; any operational or regulatory issues affecting these key players could disrupt the global supply chain.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at boosting domestic API production and reducing reliance on imports. As of November 2025, the sixth application round under the PLI scheme was launched, targeting priority APIs to enhance self-sufficiency. While this initiative is a positive step, its impact on reducing supplier concentration in the Indomethacin market remains to be seen.

Access Complete Indomethacin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,248 transactions across 70 markets.

Request Demo View Pricing

Frequently Asked Questions — Indomethacin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top indomethacin exporters from India?

The leading indomethacin exporters from India are HETERO LABS LIMITED, GLENMARK PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED, and 12 others. HETERO LABS LIMITED leads with 41.6% market share ($3.9M). The top 5 suppliers together control 76.5% of total export value.

What is the total export value of indomethacin from India?

The total export value of indomethacin from India is $9.4M, recorded across 1,248 shipments from 139 active exporters to 70 countries. The average shipment value is $7.5K.

Which countries import indomethacin from India?

India exports indomethacin to 70 countries. The top importing countries are UNITED STATES (68.0%), CANADA (4.3%), UGANDA (3.3%), CHILE (2.9%), TAJIKISTAN (2.4%), which together account for 80.9% of total export value.

What is the HS code for indomethacin exports from India?

The primary HS code for indomethacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Indomethacin

Indomethacin

Top Indomethacin Exporters from India

Top Countries Importing Indomethacin from India

Who Supplies Indomethacin to India?

Quick Facts

Related Analgesics & Antipyretics

Related Analysis

Need Details?

Regulatory Landscape — Indomethacin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Indomethacin

Supply Chain Risk Assessment — Indomethacin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Indomethacin Trade Intelligence

Frequently Asked Questions — Indomethacin Exports from India

Who are the top indomethacin exporters from India?

What is the total export value of indomethacin from India?

Which countries import indomethacin from India?

What is the HS code for indomethacin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of indomethacin exports from India?

Which ports handle indomethacin exports from India?

Why is India a leading exporter of indomethacin?

What certifications do Indian indomethacin exporters need?

How many buyers import indomethacin from India?

What is the market share of the top indomethacin exporter from India?

Analysis Methodology